Artwork

תוכן מסופק על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
Player FM - אפליקציית פודקאסט
התחל במצב לא מקוון עם האפליקציה Player FM !

86: Estradiol After 65 - Decreases Cancer and Dementia Prolongs Life

31:55
 
שתפו
 

Manage episode 413248611 series 3462922
תוכן מסופק על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65.

The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.

Episode Highlights

  • Hormone replacement therapy (HRT) beyond the age of 65
  • Results of a new study published by NAMS
  • How they're associating HRT with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia
  • Individualized hormone therapy, lower doses, and non-oral routes of administration are recommended for optimal health outcomes.
  • Estrogen-only therapy, specifically transdermal estrogen with progesterone, is beneficial and prolongs life.
  • The study challenges the previous negative views on HRT for women over the age of 65 and provides evidence for the benefits of hormone therapy in improving women's health.
  • Why women should discuss hormone therapy options with their healthcare providers and consider the potential benefits and risks based on their individual needs and health conditions.

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | The Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archtype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

  continue reading

88 פרקים

Artwork
iconשתפו
 
Manage episode 413248611 series 3462922
תוכן מסופק על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי Shawn Tassone MD PhD and Shawn Tassone MD PHD או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65.

The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.

Episode Highlights

  • Hormone replacement therapy (HRT) beyond the age of 65
  • Results of a new study published by NAMS
  • How they're associating HRT with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia
  • Individualized hormone therapy, lower doses, and non-oral routes of administration are recommended for optimal health outcomes.
  • Estrogen-only therapy, specifically transdermal estrogen with progesterone, is beneficial and prolongs life.
  • The study challenges the previous negative views on HRT for women over the age of 65 and provides evidence for the benefits of hormone therapy in improving women's health.
  • Why women should discuss hormone therapy options with their healthcare providers and consider the potential benefits and risks based on their individual needs and health conditions.

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | The Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archtype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

  continue reading

88 פרקים

כל הפרקים

×
 
Loading …

ברוכים הבאים אל Player FM!

Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.

 

מדריך עזר מהיר